Promoter polymorphisms of DNMT3B and the risk of colorectal cancer in Chinese: A case-control study

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Fan, Hong ^a   Zhang, Feng ^a   Hu, Jiabo ^b   Liu, Dongsheng ^a   Zhao, Zhujiang ^a  

^a SOUTHEAST UNIVERSITY   (China)

^b JIANGSU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE 3B; DNA (CYTOSINE 5) METHYLTRANSFERASE;

ADULT; AGED; ARTICLE; CANCER RISK; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DNA METHYLATION; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; ASIAN; CASE CONTROL STUDY; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MOLECULAR GENETICS; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RISK FACTORS;

EID: 52949115352     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-24     Document Type: Article

References (44)

1. DNA methylation and cancer. RL Momparler V Bovenzi, J Cell Physiol 2000 183 145 154 10.1002/(SICI)1097-4652(200005)183:2<145::AID-JCP1>3.0.CO;2-V 10737890
2. A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. H Shen L Wang MR Spitz WK Hong L Mao Q Wei, Cancer Res 2002 62 4992 4495 12208751
3. common functional polymorphism (C - >A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. T Skoog FM van't Hooft B Kallin S Jovinge S Boquist J Nilsson P Eriksson A Hamsten, Hum Mol Genet 1999 8 1443 1449 10.1093/hmg/8.8.1443 10400991
4. Epigenetics in cancer. M Esteller, N Engl J Med 2008 358 1148 1159 10.1056/NEJMra072067 18337604
5. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. N Beaulieu S Morin IC Chute MF Robert H Nguyen AR MacLeod, J Biol Chem 2002 277 28176 28181 10.1074/jbc.M204734200 12015329
6. Cancer epigenetics comes of age. PA Jones PW Laird, Nat Genet 1999 21 163 167 10.1038/5947 9988266
7. Transgenic mice for the preparation of hygromycin-resistant primary embryonic fibroblast feeder layers for embryonic stem cell selections. KA Johnson CP Lerner LC Di Lacio PW Laird AH Sharpe EM Simpson, Nucleic Acids Res 1995 23 1273 1275 7739908 10.1093/nar/23.7.1273
8. The CpG dinucleotide and human genetic disease. DN Cooper H Youssoufian, Hum Genet 1988 78 1511 1515
9. Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. KE Bachman MR Rountree SB Baylin, J Biol Chem 2001 276 32282 2287 10.1074/jbc.M104661200 11427539
10. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. M Okano DW Bell DA Haber E Li, Cell 1999 99 247 257 10.1016/S0092-8674(00)81656-6 10555141
11. Molecular enzymology of the catalytic domains of the Dnmt3a and Dnmt3b DNA methyltransferases. H Gowher A Jeltsch, J Biol Chem 2002 277 20409 20414 10.1074/jbc.M202148200 11919202
12. DNA methylation, methyltransferases, and cancer. KD Robertson, Oncogene 2001 20 3139 3155 10.1038/sj.onc.1204341 11420731
13. LOI of IGF2 is associated with esophageal cancer and linked to methylation status of IGF2 DMR. W Xu H Fan X He J Zhang W Xie, J Exp Clin Cancer Res 2006 25 543 547 17310846
14. Lower expression of p14ARF and p16INK4a correlates with higher DNMT3B expression in human oesophageal squamous cell carcinomas. A Simão Tde GL Simões FS Ribeiro DA Cidade NA Andreollo LR Lopes JM Macedo R Acatauassu AM Teixeira I Felzenszwalb LF Pinto RM Albano, Hum Exp Toxicol 2006 25 515 522 10.1191/0960327106het649oa 17017004
15. A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. L Wang J Wang S Sun M Rodriguez P Yue SJ Jang L Mao, Int J Oncol 2006 29 201 207 16773201
16. Distinct DNA methylation activity of Dnmt3a and Dnmt3b towards naked and nucleosomal DNA. H Takeshima I Suetake H Shimahara K Ura S Tate S Tajima, J Biochem 2006 139 503 515 10.1093/jb/mvj044 16567415
17. Differential mRNA expression of the human DNA methyltransferases (DNMTs) 1, 3a and 3b during the G(0)/G(1) to S phase transition in normal and tumor cells. KD Robertson K Keyomarsi FA Gonzales M Velicescu PA Jones, Nucleic Acids Res 2000 28 2108 2113 10773079 10.1093/nar/28.10.2108
18. DNA methylation: past, present and future directions. KD Robertson PA Jones, Carcinogenesis 2000 21 461 467 10.1093/carcin/21.3.461 10688866
19. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. YM Wang R Wang DG Wen Y Li W Guo N Wang LZ Wei YT He ZF Chen XF Zhang JH Zhang, World J Gastroenterol 2005 11 3623 3627 15962389
20. Genetic variants in epigenetic genes and breast cancer risk. A Cebrian PD Pharoah S Ahmed S Ropero MF Fraga PL Smith D Conroy R Luben B Perkins DF Easton AM Dunning M Esteller BA Ponder, Carcinogenesis 2006 27 1661 1669 10.1093/carcin/bgi375 16501248
21. Polymorphism in DNMT3B6 promoter region and lung cancer risk. L Wang M Rodriguez P Yue SY Sun WK Hong L Mao, Proc Am Assoc Cancer Res 2001 42 863
22. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer. L Wang M Rodriguez ES Kim Y Xu N Bekele AK El-Naggar WK Hong L Mao YW Oh, Int J Oncol 2004 25 993 999 15375549
23. The DNMT3B C/T promoter polymorphism and risk of breast cancer in a British population: a case-control study. KG Montgomery MC Liu DM Eccles IG Campbell, Breast Cancer Res 2004 6 R390 R394 15217506 10.1186/bcr807
24. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. JS Jones CI Amos M Pande X Gu J Chen IM Campos Q Wei M Rodriguez-Bigas PM Lynch ML Frazier, Cancer Epidemiol Biomarkers Prev 2006 15 886 891 10.1158/1055-9965.EPI-05-0644 16702365
25. A simple salting out procedure for extracting DNA from human nucleated cells. SA Miller DD Dykes HF Polesky, Nucleic Acids Res 1988 16 1215 3344216 10.1093/nar/16.3.1215
26. DNMT3B polymorphisms and risk of primary lung cancer. SJ Lee HS Jeon JS Jang SH Park GY Lee BH Lee CH Kim YM Kang WK Lee S Kam RW Park IS Kim YL Cho TH Jung JY Park, Carcinogenesis 2005 26 403 409 10.1093/carcin/bgh307 15528220
27. DNMT3B 39179GT polymorphism and the risk of adenocarcinoma of the colorectal in Koreans. YS Hong HJ Lee CH You MS Roh JY Kwak MJ Lee JY Kim, Biochem Genet 2007 45 155 163 10.1007/s10528-006-9047-9 17318376
28. A simple salting out procedure for extracting DNA from human nucleated cells. SA Miller DD Dykes HF Polesky, Nucleic Acids Res 1988 16 1215 3344216 10.1093/nar/16.3.1215
29. Colorectal serrated adenocarcinoma. MJ Mäkinen, Histopathology 2007 50 131 150 10.1111/j.1365-2559.2006.02548.x 17204027
30. DNA methyltransferases. TH Bestor GL Verdine, Curr Opin Cell Biol 1994 6 380 389 10.1016/0955-0674(94)90030-2 7917329
31. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. KD Robertson E Uzvolgyi G Liang C Talmadge J Sumegi FA Gonzales PA Jones, Nucleic Acids Res 1999 27 2291 2298 10325416 10.1093/nar/27.11.2291
32. Dynamics of DNA methylation pattern. CL Hsieh, Curr Opin Genet Dev 2000 10 224 228 10.1016/S0959-437X(00)00064-2 10753782
33. Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. KP Chang SP Hao CT Liu MH Cheng YL Chang YS Lee TH Wang CN Tsai, Oral Oncol 2007 43 345 351 10.1016/j. oraloncology.2006.04.006 16920385
34. DNA methyltransferase 3B promoter polymorphism and its susceptibility to primary hepatocellular carcinoma in the Chinese Han nationality population: a case-control study. Y Wu JS Lin, World J Gastroenterol 2007 13 6082 6086 10.3748/wjg.13.6082 18023104
35. Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. YM Wang R Wang DG Wen Y Li W Guo N Wang LZ Wei YT He ZF Chen XF Zhang JH Zhang, World J Gastroenterol 2005 11 3623 3627 15962389
36. No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. PP Aung S Matsumura K Kuraoka K Kunimitsu K Yoshida K Matsusaki H Nakayama W Yasui, Oncol Rep 2005 14 1151 1154 16211278
37. DNMT3B 579 G>T promoter polymorphism and risk of esophagus carcinoma in Chinese. H Fan DS Liu SH Zhang JB Hu F Zhang ZJ Zhao, World J Gastroenterol 2008 14 2230 2234 10.3748/wjg.14.2230 18407600
38. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer. J Wang G Walsh DD Liu JJ Lee L Mao, Cancer Res 2006 66 8361 8366 10.1158/0008-5472.CAN- 06-2031 16951144
39. Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis. Y Saito Y Kanai M Sakamoto H Saito H Ishii S Hirohashi, Proc Natl Acad Sci USA 2002 99 10060 10065 12110732 10.1073/pnas.152121799
40. A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation. T Chen Y Ueda S Xie E Li, J Biol Chem 2002 277 38746 38754 10.1074/jbc.M205312200 12138111
41. DNA methyltransferase 3b contributes to oncogenic transformation induced by SV40T antigen and activated Ras. K Soejima W Fang BJ Rollins, Oncogene 2003 22 4723 4733 10.1038/sj.onc.1206510 12879017
42. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. DJ Weisenberger M Velicescu JC Cheng FA Gonzales G Liang PA Jones, Mol Cancer Res 2004 2 62 72 14757847
43. Hypermethylation of the inducible nitric-oxide synthase gene promoter inhibits its transcription. Z Yu BC Kone, J Biol Chem 2004 279 46954 46961 10.1074/jbc.M407192200 15308624
44. Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression. SH Kim J Park MC Choi HP Kim JH Park Y Jung JH Lee DY Oh SA Im YJ Bang TY Kim, Biochem Biophys Res Commun 2007 355 318 323 10.1016/j.bbrc.2007.01.187 17303076